March 28, 2022

Vela Diagnostics présente ses panels de séquençage des gènes du cancer ciblés (60 gènes) et complets (525 gènes) basés sur les NGS

HAMBOURG, Allemagne, 28 mars 2022 /PRNewswire/ — Vela Diagnostics a annoncé aujourd’hui le lancement de ses nouveaux panels de séquençage OncoKey® SL 60 et 525 Plus. Ces panels basés sur les systèmes de séquençage de nouvelle génération (NGS) sont conçus pour détecter les biomarqueurs d’ADN et d’ARN du cancer à partir d’échantillons de tissus fixés au formol et inclus en […]

Continue Reading →

Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels

HAMBURG, Germany, March 28, 2022 /PRNewswire/ — Vela Diagnostics announced today the launch of its new OncoKey® SL 60 and 525 Plus Panels. These next-generation sequencing (NGS)-based panels are intended for detection of DNA and RNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue specimens, for up to 64 samples in a single sequencing run. Vela […]

Continue Reading →

Presales Open for Metahunter: The Metaverse for All

The combination of MMORPG, Sandbox, and open-world concepts opens the door to a new Metaverse. SINGAPORE, March 28, 2022 /PRNewswire/ — A new dawn is coming to the virtual world in the shape of Metahunter, a platform that is focused on accessibility, education, and opportunity for any and all who want to experience the metaverse. […]

Continue Reading →